This study is comparing a new vibrating pelvic floor device called "Kiwi" to traditional vaginal dilators for women who experience genito-pelvic pain/penetration disorder (GPPPD), which can include painful intercourse (dyspareunia) or muscle spasms (vaginismus). The goal is to see if the Kiwi device improves sexual function more effectively than traditional dilators. Researchers will measure sexual function using a questionnaire called the Female Sexual Function Index (FSFI) after four weeks. You may be able to join if you are a woman, 18 years or older, assigned female at birth, and have a diagnosis of GPPPD. The current status of this study is unclear, and it plans to enroll 60 participants.

Study design

This is a randomized controlled trial, meaning participants will be randomly assigned to either the Kiwi device group or the traditional dilator group. The study plans to enroll 60 women.

What's involved

You would use your assigned device three times per week for 15 minutes per session over a four-week period. Data will be collected at the beginning and end of the study using questionnaires.

Compensation

Not stated in the trial record.

Follow-up

Your sexual function will be measured at four weeks, which is the end of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.